FDA OKs first at-home test for 3 STIs
Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and ...
Diagnostic technology achieves near 100% accuracy in pathogen identification within three hours
Hajun Kim, Taejoon Kwon, and Joo Hun Kang—from the Department of Biomedical Engineering at UNIST has unveiled a novel ...
MPR3d
FDA Clears OTC Test for Chlamydia, Gonorrhea and Trichomoniasis
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual Health
Visby Medical™, a leading innovator in medical diagnostics, announced that the U.S. Food and Drug Administration (FDA) has ...
BetaKit3d
BioAlert secures $2.5 million to help companies detect and manage harmful pathogens in water
Sherbrooke, Que.-based BioAlert Solutions has raised a $2.5-million seed round to expand the reach of its automated water ...
Medscape6d
Acute Arthritis in Traveller Reveals Rare Viral Infection
This case emphasises the need for early recognition and proper diagnosis of CHIKV infection in patients with acute joint pain ...
EurekAlert!12d
Pediatric investigation study releases updated guidelines for pediatric mycoplasma pneumoniae infection
The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children.